Archive for June, 2010

Stem-cell furore erupts

Data analysis ignites public row.

Tarix Pharmaceuticals’ TXA127 Receives FDA Orphan Drug Designation For Stem Cell Engraftment

Tarix Pharmaceuticals ( www.tarixpharma.com ) today announced that it’s drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant.

Stem cell reporting by universities part of state budget debate

LANSING — Right to Life of Michigan will continue to push for requiring public universities that do embryonic stem cell research to report some information to the state.

Extracted Teeth Could Be Easy Source Of Stem Cells

New research from Japan suggests that dental pulp from extracted teeth may be an easy source of Induced Pluripotent Stem (IPS) cells, which like embryonic stem cells, have the potential to form several different cell types, but without the controversial ethical problems. These were the findings of a study led by K…

Stem cell reports part of Michigan budget debate

LANSING — Right to Life of Michigan will continue to push for requiring public universities that do embryonic stem cell research to report some information to the state.

Stem cell co Pluristem advances in clinical trial process

The company obtained a $2.5 million Chief Scientist grant to cover R&D expenses.

Kyoto Prize Winner’s Stem Cell Work Intrigues Local Researchers

A medical researcher involved in creating a specialized type of stem cell — one that has captured the attention of some San Diego life sciences organizations — is among the three winners in the latest round of Kyoto Prizes.

Mechanism that regulates stem-cell differentiation in mice may trigger degenerative disease in humans: Research

A mechanism that regulates stem-cell differentiation in mice testes suggests a similar process that may trigger degenerative disease in humans, according to a Penn State College of Agricultural Sciences reproductive physiologist.

Tarix Pharma stem cell transplant drug wins orphan drug status

Virtual biotechnology firm Tarix Pharmaceuticals Ltd. has won orphan drug designation from the U.S. Food and Drug Administration for TXA127, its drug target used in the engraftment of stem cell transplant patients.

Boy undergoes stem cell treatment

A nine-year-old boy with a rare neurological disorder which renders him without speech has had radical stem cell treatment in Dusseldorf, Germany.